Zynerba Pharmaceuticals Stock Forecast
Recent Zynerba Pharmaceuticals Stock Price |
|
Zynerba Pharmaceuticals Stock Forecast Price |
$0.00 |
NA% |
$0.00 |
As of
Recent Zynerba Pharmaceuticals Analyst Ratings Breakdown |
|
Current |
1 Mo. Ago |
2 Mo. Ago |
3 Mo. Ago |
Strong buy ratings: |
|
|
|
|
Buy ratings: |
|
|
|
|
Hold ratings: |
|
|
|
|
Sell ratings: |
|
|
|
|
Strong sell ratings: |
|
|
|
|
Average rating: |
|
|
|
|
In the last row of the above table, the average rating presented is from 1 to 5 where 1 means Strong Buy and 5 means Strong Sell.
The presented Zynerba Pharmaceuticals stock forecast (traded under symbol ZYNE), for forward-twelve-months price target as shown at the top of this page, gives you the average Zynerba Pharmaceuticals stock forecast for forward target price for symbol ZYNE, across the analysts covering Zynerba Pharmaceuticals (ZYNE), as reported in
data provided by Zacks Investment Research via Quandl.com.
Investors should also take note that the median Zynerba Pharmaceuticals stock forecast price target (i.e. representing the middle ground number where half of analysts had a higher Zynerba Pharmaceuticals stock forecast and half had a lower Zynerba Pharmaceuticals stock forecast) was $ as of (which is a different mathematical metric versus taking the average or mean), while the
highest Zynerba Pharmaceuticals stock forecast in the analyst group was $, and the lowest Zynerba Pharmaceuticals stock forecast in the analyst group was
$, with a standard deviation of $. Get the latest Zacks research report on ZYNE — FREE
Top Analyst Picks of the Dow
The Top 20 Largest U.S. Stocks By Market Cap
|
May 1, 2024 12:26 AM Eastern
Hold (2.00 out of 4)
100th percentile
|
|